ABS Investment Management LLC Makes New Investment in Teladoc Health, Inc. $TDOC

ABS Investment Management LLC acquired a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 178,438 shares of the health services provider's stock, valued at approximately $1,513,154. Teladoc Health makes up about 0.0% of ABS Investment Management LLC's investment portfolio, making the stock its 28th largest holding. ABS Investment Management LLC owned about 0.10% of Teladoc Health as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in TDOC. Allworth Financial LP bought a new stake in Teladoc Health in the 2nd quarter worth about $25,000. EverSource Wealth Advisors LLC grew its position in Teladoc Health by 694.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider's stock worth $31,000 after purchasing an additional 4,945 shares in the last quarter. PNC Financial Services Group Inc. grew its position in Teladoc Health by 177.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider's stock worth $31,000 after purchasing an additional 2,810 shares in the last quarter. IFP Advisors Inc grew its position in Teladoc Health by 412.1% in the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider's stock worth $31,000 after purchasing an additional 3,210 shares in the last quarter. Finally, EFG International AG bought a new position in shares of Teladoc Health during the 2nd quarter valued at approximately $35,000. 76.82% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on TDOC. Weiss Ratings reissued a "sell (d-)" rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, July 30th. Bank of America increased their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a research report on Tuesday, July 7th. Finally, Citigroup reduced their target price on shares of Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research report on Monday, August 3rd. Five research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $7.54.

Insider Buying and Selling at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 5,677 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $43,315.51. Following the completion of the transaction, the insider directly owned 9,572 shares of the company's stock, valued at approximately $73,034.36. This trade represents a 37.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the transaction, the insider directly owned 57,671 shares of the company's stock, valued at approximately $440,029.73. This trade represents a 9.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 39,195 shares of company stock valued at $299,058 in the last quarter. Corporate insiders own 0.70% of the company's stock.

Teladoc Health Stock Up 2.4%

Teladoc Health stock opened at $6.51 on Friday. Teladoc Health, Inc. has a twelve month low of $4.40 and a twelve month high of $9.89. The firm has a 50 day moving average price of $7.94 and a 200-day moving average price of $6.64. The company has a market capitalization of $1.18 billion, a P/E ratio of -6.58 and a beta of 2.12.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.04. The company had revenue of $606.93 million during the quarter, compared to the consensus estimate of $615.44 million. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. Teladoc Health's revenue for the quarter was down 4.0% on a year-over-year basis. During the same period last year, the firm earned ($0.19) EPS. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. Equities analysts expect that Teladoc Health, Inc. will post -0.89 EPS for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source